|
Roche says Herceptin with Pertuzumab "impressive"
Roche Holding AG's Herceptin combined with pertuzumab showed"impressive results" in a phase II breast cancer trial, the Swissdrugmaker said on Friday.
More... |
| All times are GMT -7. The time now is 03:19 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021